These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17336444)

  • 1. The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I.
    Capranico G; Ferri F; Fogli MV; Russo A; Lotito L; Baranello L
    Biochimie; 2007 Apr; 89(4):482-9. PubMed ID: 17336444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA topoisomerase i as a transcription protein and a lethal cellular toxin.
    Lotito L; Ferri F; Russo A; Capranico G
    Ital J Biochem; 2007 Jun; 56(2):122-9. PubMed ID: 17722653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells.
    Khobta A; Ferri F; Lotito L; Montecucco A; Rossi R; Capranico G
    J Mol Biol; 2006 Mar; 357(1):127-38. PubMed ID: 16427078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camptothecin inhibits hsp 70 heat-shock transcription and induces DNA strand breaks in hsp 70 genes in Drosophila.
    Rowe TC; Couto E; Kroll DJ
    NCI Monogr; 1987; (4):49-53. PubMed ID: 2819731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of flexibility and long range communication on the function of human topoisomerase I.
    Chillemi G; Fiorani P; Bruselles A; Castelli S; Campagna A; Sarra O; Tesauro C; Fiorentini M; Vassallo O; D'Annessa I; Santoleri S; Desideri A
    Ital J Biochem; 2007 Jun; 56(2):110-4. PubMed ID: 17722651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells.
    Solier S; Lansiaux A; Logette E; Wu J; Soret J; Tazi J; Bailly C; Desoche L; Solary E; Corcos L
    Mol Cancer Res; 2004 Jan; 2(1):53-61. PubMed ID: 14757846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
    Chrencik JE; Staker BL; Burgin AB; Pourquier P; Pommier Y; Stewart L; Redinbo MR
    J Mol Biol; 2004 Jun; 339(4):773-84. PubMed ID: 15165849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells.
    Listerman I; Sapra AK; Neugebauer KM
    Nat Struct Mol Biol; 2006 Sep; 13(9):815-22. PubMed ID: 16921380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleosomes represent a physical barrier for cleavage activity of DNA topoisomerase I in vivo.
    Di Felice F; Chiani F; Camilloni G
    Biochem J; 2008 Feb; 409(3):651-6. PubMed ID: 17967163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational information in DNA: its role in the interaction with DNA topoisomerase I and nucleosomes.
    Caserta M; Camilloni G; Venditti S; Venditti P; Di Mauro E
    J Cell Biochem; 1994 May; 55(1):93-7. PubMed ID: 8083304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of topoisomerase I with transcriptionally active loci in Drosophila.
    Gilmour DS; Elgin SC
    NCI Monogr; 1987; (4):17-21. PubMed ID: 2819725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription.
    Bendixen C; Thomsen B; Alsner J; Westergaard O
    Biochemistry; 1990 Jun; 29(23):5613-9. PubMed ID: 1696837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
    Zhang H; Wang JC; Liu LF
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: implications for physiological and therapeutic modulation of enzyme activity.
    Capranico G; Marinello J; Baranello L
    Biochim Biophys Acta; 2010 Dec; 1806(2):240-50. PubMed ID: 20600630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camptothecin: current perspectives.
    Thomas CJ; Rahier NJ; Hecht SM
    Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
    Lotito L; Russo A; Bueno S; Chillemi G; Fogli MV; Capranico G
    Eur J Pharmacol; 2009 Jan; 603(1-3):29-36. PubMed ID: 19094980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
    Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
    Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerases of kinetoplastid parasites: why so fascinating?
    Das BB; Sengupta T; Ganguly A; Majumder HK
    Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.
    Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
    Biochem Pharmacol; 2008 Mar; 75(6):1272-81. PubMed ID: 18191106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.